Studies offer insights into the health risks and burdens faced by people who have had COVID infections. Meanwhile, the Trump ...

The 2025-26 Pfizer COVID-19 vaccine is about 57% effective against emergency department/urgent care (ED/UC) visits and 54% ...

The BNT162b2 KP.2 vaccine effectively prevents severe COVID-19 outcomes, including hospitalizations and ED or UC visits.

The Navy announced an apology and a path to reinstatement for service members discharged over the COVID-19 vaccine mandate as ...

Most COVID-19 vaccine hesitancy is rooted in concerns that can be addressed and effectively reduced over time, according to a new study following more than 1.1 million people in England between ...

In late December, Winmill issued an order granting the company’s request for a summary judgment and dismissing all of Skidmore and Dance’s claims. He dismissed them with prejudice, meaning the ...

America's pediatricians and the Centers for Disease Control and Prevention were once in lockstep on how vaccines impact child ...

Robert Kramer was the CEO of Emergent BioSolutions, a government contractor.

The University of Auckland is hosting the research as part of the Global COVID Vaccine Safety (GCoVS) Project. Scientists ...

Findings reveal a general decline in vaccine hesitancy during the 15 months following the COVID-19 vaccine roll-out in 2021-2022, with almost two-thirds of those initially hesitant going on to receive ...

Robert G. Kramer sold nearly 90,000 shares of his stock in Emergent BioSolutions, knowing that large quantities of vaccine ...

A study aimed to compare corneal topographic and specular microscopic parameters both before and after patients received the ...